XSHE
002748
Market cap446mUSD
Oct 09, Last price
12.26CNY
1D
-1.53%
1Q
9.27%
Jan 2017
-36.10%
IPO
6.37%
Name
Jiangxi Selon Industrial Co Ltd
Chart & performance
P/E
51.08
P/S
1.47
EPS
0.24
Div yield, %
0.40%
Shrs. gr., 5y
—
Rev. gr., 5y
-1.65%
Revenues
2.00b
+0.84%
Net income
58m
+120.12%
CFO
41m
-76.05%
Dividend
Jul 09, 20260.075 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Leping, China, in 2003, Jiangxi Selon Industrial Co., Ltd. is a Chinese enterprise specializing in the comprehensive lifecycle of fine chemicals. The company conducts research, development, manufacturing, marketing, and sales of its product range. This portfolio includes AC foaming agents, thionyl chloride, and chlor-alkali compounds, alongside industrial-grade chemicals such as sodium hydroxide, liquid chlorine, synthetic hydrochloric acid, and aqueous ammonia. Furthermore, Jiangxi Selon extends its market reach globally, exporting its chemical solutions to approximately 30 nations across Southeast Asia, Central Asia, Europe, Latin America, and Africa.
Key people
Yiyun Liu
Vice Chairman of the Board · since 2022
Miaohua Pan
Chief Financial Officer · since 2025
Wenming Cheng
Deputy General Manager · since 2025
Shoufa Wang
Deputy General Manager, Chief Engineer · since 2017
Jiaolong Li
Deputy General Manager, Secretary of the Board · since 2022
Guoqing Wang
Chairman of the Board, General Manager · since 2021
Jinhua Jiang
Independent Director · since 2022
Independent Director · since 2022
Le Wen
Independent Director · since 2022
Headquarters & legal address
江西省景德镇市乐平市接渡镇（世龙公司3栋行政办公楼）
景德镇市, JX 333300
CN
景德镇市, JX 333300
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||